ES400318A1 - Method of obtaining phosphoric esters antagonists of prostaglandin. (Machine-translation by Google Translate, not legally binding) - Google Patents

Method of obtaining phosphoric esters antagonists of prostaglandin. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES400318A1
ES400318A1 ES400318A ES400318A ES400318A1 ES 400318 A1 ES400318 A1 ES 400318A1 ES 400318 A ES400318 A ES 400318A ES 400318 A ES400318 A ES 400318A ES 400318 A1 ES400318 A1 ES 400318A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
phenyl
formula
see formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES400318A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Pharmaceuticals Inc filed Critical Allergan Pharmaceuticals Inc
Publication of ES400318A1 publication Critical patent/ES400318A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/242Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Method for obtaining prostaglandin antagonist phosphoric esters, which have the following structural formula: **(See formula)** wherein R1 is one of -H, -OH, alkyl or alkoxy having 1-3 carbon atoms; R2 is one of -H, -Cl, -F, -CF3, alkyl having 1-3 carbon atoms; R3, R4, and R5 are each one of -H, -OH, halogen, nitro, or alkyl and alkoxy having 1-3 carbon atoms; R6 is one of -H, -F, phenyl, -OH, -Cl, alkyl having 1-3 carbon atoms, -CH2OH or -C2H4OH; Z is optionally a radical of the formula **(See formula)** and t is one of -H, -CH3, -F, -C1 or -OCH3; R7 is optionally one of an alkyl group having 1-6 carbon atoms, OCOCH3 and CH2-phenyl, C2H4-phenyl, C3H6-phenyl or C3H6-m-OH-phenyl; R8 and R9 are each one between H, F, Cl, OH, CH2OH, C2H4OH, alkyl having 1-3 carbon atoms, **(See formula)** (see formula) where m is 1-6 and R is one among H, CH3 or C2H5; M is H or a pharmaceutically acceptable salt thereof, characterized in that a substituted dihydrocalcone having the following formula is reacted: **(See formula)** wherein R1-R9 and Z are defined as above, with a phosphorylating agent in a solvent capable of promoting phosphorylation and optionally hydrolyzing the reaction product to produce the target compounds. (Machine-translation by Google Translate, not legally binding)
ES400318A 1971-03-01 1972-03-01 Method of obtaining phosphoric esters antagonists of prostaglandin. (Machine-translation by Google Translate, not legally binding) Expired ES400318A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11979471A 1971-03-01 1971-03-01
GB603571 1971-03-04

Publications (1)

Publication Number Publication Date
ES400318A1 true ES400318A1 (en) 1975-06-16

Family

ID=26240352

Family Applications (1)

Application Number Title Priority Date Filing Date
ES400318A Expired ES400318A1 (en) 1971-03-01 1972-03-01 Method of obtaining phosphoric esters antagonists of prostaglandin. (Machine-translation by Google Translate, not legally binding)

Country Status (5)

Country Link
BE (1) BE779997A (en)
DE (1) DE2209595A1 (en)
ES (1) ES400318A1 (en)
FR (1) FR2128436A1 (en)
NL (1) NL7202645A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175425A2 (en) 1999-01-21 2002-01-30 The Board Of Regents, The University Of Texas System Inhibitors of intestinal apical membrane na/phosphate co-transportation
JP5067916B2 (en) * 2005-10-05 2012-11-07 丸善製薬株式会社 Skin cosmetics and hair cosmetics

Also Published As

Publication number Publication date
BE779997A (en) 1972-06-16
NL7202645A (en) 1972-09-05
DE2209595A1 (en) 1972-09-21
FR2128436A1 (en) 1972-10-20

Similar Documents

Publication Publication Date Title
ES369005A1 (en) Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins
ES456279A1 (en) 16,17,18,19,20-pentanorprostaglandins
ES431055A1 (en) N-{8 (Methoxymethyl-furyl)-methyl{9 -morphinans or -6,7-benzomorphans and salts thereof
ES402627A1 (en) Procedure for the obtaining of prostate acid derivatives. (Machine-translation by Google Translate, not legally binding)
ES332806A1 (en) A method of preparing acetals. (Machine-translation by Google Translate, not legally binding)
ES400318A1 (en) Method of obtaining phosphoric esters antagonists of prostaglandin. (Machine-translation by Google Translate, not legally binding)
ES414343A1 (en) Cyclopentane derivatives
ES442887A1 (en) D-6-methyl-2,8-disubstituted ergolines
ES397603A1 (en) Benzobicycloalkane compounds
ES446694A1 (en) Biphenyl derivatives and pharmaceutical compositions thereof
ES386327A1 (en) Organic compounds for use as fuel additives
ES205007A1 (en) Process for the production of delta2-oxazolines
ES417884A1 (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them
ES393340A1 (en) Amines and a process for the manufacture thereof
ES395155A1 (en) Method for the preparation of antibiotics and intermediates
ES403786A1 (en) A procedure for the preparation of new esters of the 2-alcohil-tiazol-5-carboxylic acid. (Machine-translation by Google Translate, not legally binding)
ES411737A1 (en) Heterocyclic triglycidyl compounds and a process for their production
ES436029A1 (en) A procedure for the preparation of chromanols. (Machine-translation by Google Translate, not legally binding)
ES203714A1 (en) Bis-(substituted phenyl)-thioureas
CH613940A5 (en) Process for the preparation of alkyl ethers substituted by substituted phenyl
FR2294701A1 (en) BETA-LACTAMASE INHIBITORS AND PROCESS FOR THEIR PREPARATION
ES302224A1 (en) Procedure for the manufacture of heterociclic compounds. (Machine-translation by Google Translate, not legally binding)
ES414805A1 (en) [NOVEL] ESTERS OF alpha-CARBOXYBENZYLPENCILLIN
ES431234A1 (en) 15{40 ,16{40 -Lower alkoxymethylidene-digitoxins
ES409446A1 (en) Process for the preparation of methyl jasmonate